Basit öğe kaydını göster

dc.contributor.authorDemirelli, FUAT HULUSİ
dc.contributor.authorMandel, Nil Kler
dc.contributor.authorOzguroglu, Mustafa
dc.contributor.authorDemir, G
dc.date.accessioned2021-03-03T11:36:11Z
dc.date.available2021-03-03T11:36:11Z
dc.date.issued1999
dc.identifier.citationOzguroglu M., Demir G., Demirelli F. H. , Mandel N. K. , "Anaphylaxis from intraperitoneal infusion of cisplatin - A case report", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.22, sa.2, ss.172-173, 1999
dc.identifier.issn0277-3732
dc.identifier.otherav_28ce9914-86f4-42c1-9209-4caff5bea019
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/32282
dc.identifier.urihttps://doi.org/10.1097/00000421-199904000-00013
dc.description.abstractAnaphylactic reactions to platinum compounds and paclitaxel are well-recognized complications during their systemic administration. Although there have been reports describing anaphylaxis during intravesical instillation of chemotherapeutic agents, to the best of the authors' knowledge, no hypersensitivity reactions after intraperitoneal administration of chemotherapeutic drugs has been reported in the English literature. The authors report an unusual case of anaphylaxis occurring in a 33-year-old woman who has been treated with paclitaxel and cisplatin for ovarian cancer. She developed a hypersensitivity reaction during her ninth cycle of chemotherapy, immediately after institution of intraperitoneal infusion of cisplatin. it is important to be aware of the possibility of anaphylaxis during chemotherapy administration other than the systemic route go that appropriate premedication or effective treatment can be promptly instituted.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleAnaphylaxis from intraperitoneal infusion of cisplatin - A case report
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume22
dc.identifier.issue2
dc.identifier.startpage172
dc.identifier.endpage173
dc.contributor.firstauthorID14580


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster